Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism
In a randomized, double-blind study of three common approaches to hypothyroidism, no significant differences in symptoms were reported.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

1 in 3 on Levothyroxine Take Meds That Interfere With Thyroid Tests 1 in 3 on Levothyroxine Take Meds That Interfere With Thyroid Tests
Around a third of older patients taking levothyroxine are prescribed other drugs that can interfere with thyroid function tests, shows the first study to examine this issue.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 21, 2021 Category: Surgery Tags: Diabetes & Endocrinology News Source Type: news

1 in 3 Older Thyroid Patients Takes a Med That Can Interfere With Tests
THURSDAY, March 18, 2021 -- Nearly one-third of seniors who take thyroid hormone also take drugs known to interfere with tests of thyroid function, a new study finds. It's common for older adults to take a thyroid hormone (levothyroxine) to treat... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 18, 2021 Category: General Medicine Source Type: news

A Third Discontinuing Levothyroxine Have Normal Thyroid Levels A Third Discontinuing Levothyroxine Have Normal Thyroid Levels
Those with overt hypothyroidism are less likely to remain euthyroid than patients with subclinical disease, but many wind up restarting treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 4, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Levothyroxine Sodium Products Enforcement of August 14, 2001 Compliance Date and Submission of New Applications
Procedural (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 1, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Thyquidity (Levothyroxine Sodium Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 11, 2020 Category: Drugs & Pharmacology Source Type: news

Thyquidity (Levothyroxine Sodium Oral Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 10, 2020 Category: Drugs & Pharmacology Source Type: news

Euthyrox (Levothyroxine Sodium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 25, 2020 Category: Drugs & Pharmacology Source Type: news

Lannett Launches Authorized Generic of Tirosint(R) (Levothyroxine Sodium Capsules)
Unique Oral Formulation of Levothyroxine Expands Thyroid Deficiency Product Portfolio PHILADELPHIA, Nov. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced the launch of the auth... Biopharmaceuticals, Generics, Product Launch Lannnett, Tirosint, levothyroxine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 3, 2020 Category: Pharmaceuticals Source Type: news

Real-world Evidence from a Narrow Therapeutic Index Product (Levothyroxine) Reflects the Therapeutic Equivalence of Generic Drug Products
It appears that some prescribers are not aware that FDA bioequivalence standards ensure that generic products do not differ in safety, efficacy, or quality (including potency) from regulatory standards that govern brand-name products. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 2, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism
Time spent in normal thyroid range over 3 years was the same whether patients took levothyroxine or desiccated thyroid; editorial says keeping the latter in the treatment tool kit is important.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid ®, Thyroid Tablets, USP Due to Sub Potency
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid ®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots to be sub potent. The product may have (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 18, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Effect of Increased Levothyroxine Dose on Depressive Mood Effect of Increased Levothyroxine Dose on Depressive Mood
Increased doses of levothyroxine may help improve depressive symptoms among older hypothyroid patients receiving hormone replacement therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Lannett Announces Launch Of FDA Approved Levothyroxine Tablets
PHILADELPHIA, Aug. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced the launch of Cediprof, Inc.'s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusiv... Biopharmaceuticals, Endocrinology, Product Launch Lannett, Levothyroxine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 3, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not justified, the ThyrAMI-2 trialists conclude.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Thyroid Drug May Not Help After Heart Attack: Study
TUESDAY, July 21, 2020 -- If a heart attack survivor also has an underactive thyroid, treating them with supplemental thyroid hormone probably won't help, new research shows. The study found that use of the hormonal drug, called levothyroxine,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 21, 2020 Category: General Medicine Source Type: news

Bestselling Author Releases Free Deep Dive Educational Webinar and...
Nationally-known patient advocate and bestselling author Mary Shomon has launched a free educational program on levothyroxine, the most commonly prescribed medication to treat hypothyroidism, and one...(PRWeb July 21, 2020)Read the full story at https://www.prweb.com/releases/bestselling_author_releases_free_deep_dive_educational_webinar_and_book_on_levothyroxine_the_most_prescribed_medication_for_hypothyroidism/prweb17267808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 21, 2020 Category: Pharmaceuticals Source Type: news

Over 158 applications for generic products pending with USFDA for approval: Lupin
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Common Treatment, Synthroid, May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Synthroid May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Testing, Prescribing Increase After Change to TSH Reference Range
MONDAY, May 4, 2020 -- A minor planned decrease in the upper limit of the reference range for thyroid-stimulating hormone (TSH) resulted in an increase in levothyroxine prescriptions and more TSH measurements, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine Sodium Tablets - In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing
Clinical/Medical (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Patients Say Desiccated Thyroid Better Than Standard Therapy Patients Say Desiccated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 14, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Patients Say Dessicated Thyroid Better Than Standard Therapy Patients Say Dessicated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 13, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Does Thyroid Hormone Therapy in Older Age Increase Risk of Death? Does Thyroid Hormone Therapy in Older Age Increase Risk of Death?
Whether or not the mortality finding is real, one expert says, in any case, levothyroxine doesn't make older patients with subclinical hypothyroidism feel any better, so is unwarranted.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 6, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

ENDO: Thyroid Hormone Use May Up Mortality Risk in Older Adults
TUESDAY, March 31, 2020 -- Synthetic levothyroxine (LT4) is associated with an increased risk for death among older adults, according to a study presented at the virtual meeting of The Endocrine Society, held from March 28 to 31. Enoch Joseph... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine taken in the evening may have greater benefits
Hypothyroidism drug, lethothyroxine, may have greater benefits when taken at bedtime rather than breakfast, according to a study published inClinical Endocrinology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 4, 2020 Category: Endocrinology Source Type: news

Tirosint-Sol (Levothyroxine Sodium Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 2, 2020 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines Recall: Wockhardt UK Ltd, Levothyroxine 100micrograms/5ml Oral Solution
Wockhardt UK Ltd is recalling specific batches of... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 30, 2020 Category: Drugs & Pharmacology Source Type: news

Levothyroxine-induced Liver Injury Levothyroxine-induced Liver Injury
Drug-induced liver injury is rarely observed with levothyroxine therapy; this case demonstrates that it can be reversible with cessation of the drug.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Jury Still Out on Whether to Treat Subclinical Hypothyroidism in Elderly Jury Still Out on Whether to Treat Subclinical Hypothyroidism in Elderly
A new systematic review suggests elderly patients with overt hypothyroidism should receive levothyroxine treatment, but for those with subclinical hypothyroidism, the advice is less certain.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 13, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Jury Still Out on Whether to Treat Subclincal Hypothyroidism in Elderly Jury Still Out on Whether to Treat Subclincal Hypothyroidism in Elderly
A new systematic review suggests elderly patients with overt hypothyroidism should receive levothyroxine treatment, but for those with subclinical hypothyroidism, the advice is less certain.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 13, 2019 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

' Growing Concern': Incorrect Doses of Compounded Levothyroxine'Growing Concern': Incorrect Doses of Compounded Levothyroxine
"Dramatic" variations in the amount of active ingredient were found in compounded liquid versions of levothyroxine (LT4) in a new study. The"surprise" results are a cause for concern, say researchers.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 13, 2019 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Mifepristone Increases TH Requirements in Hypothyroidism Mifepristone Increases TH Requirements in Hypothyroidism
Treatment with mifepristone resulted in increased levothyroxine requirements among patients with Cushing disease and central hypothyroidism.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Outcome in Heart Failure Treated With Levothyroxine Outcome in Heart Failure Treated With Levothyroxine
A new study examines the long-term effects of levothyroxine treatment in patients with heart failure. What have we learned?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 2, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Lannett Enters Into Distribution Agreement For Levothyroxine
PHILADELPHIA, July 8, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Ce... Biopharmaceuticals, Generics, Distribution Lannett Company, Levothyroxine, Cediprof, Neolpharma Pharmaceutical Group (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 8, 2019 Category: Pharmaceuticals Source Type: news

Generic vs Brand-Name Levothyroxine: Same Cardiac Event Risk? Generic vs Brand-Name Levothyroxine: Same Cardiac Event Risk?
' There's been a lot of discussion of generic versus brand L-T4, and this is just one other piece of information in a very large group of patients, but it needs follow-up studies,'says lead author.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Similar CV Event Rates Seen for Generic, Brand Levothyroxine
THURSDAY, June 27, 2019 -- Cardiovascular event rates are similar for patients with newly treated hypothyroidism receiving generic and brand levothyroxine (L-T4), according to a study published online April 26 in the Mayo Clinic Proceedings. Robert... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2019 Category: Pharmaceuticals Source Type: news

Over-prescribed levothyroxine: Mayo Clinic Radio Health Minute
The most commonly prescribed drug in the U.S. also may be one of the most overprescribed for older individuals. Levothyroxine is a medication used to treat low thyroid hormone levels. However, a study published this spring in the New England Journal of Medicine reported that patients with subclinical thyroid hormone levels received no benefit from the drug. Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 20, 2019 Category: Databases & Libraries Source Type: news

Study finds similar cardiovascular outcomes for generic, brand-name drugs for hypothyroidism
JACKSONVILLE, Fla. -- A new study by Mayo Clinic researchers may have broad implications for treatment of patients with predominantly benign thyroid disease and newly treated hypothyroidism. The study, to be published in Mayo Clinic Proceedings in July, looked at whether generic and brand-name levothyroxine therapy affected hospitalization for cardiovascular events for those patients who [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 18, 2019 Category: Databases & Libraries Source Type: news

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration
Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg,& 120 mg to the wholesale level. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA ’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduc...
Source: FDA Center for Drug Evaluation and Research - What's New - May 24, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Why doctors now warn against routinely treating mild thyroid issues
Giving daily levothyroxine pills to people with a mild abnormality called subclinical hypothyroidism offers no benefit, a review of 21 clinical trials suggests. (Source: CBC | Health)
Source: CBC | Health - May 17, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Mild Hypothyroidism Being Overtreated, Avoid Pills, Says Panel Mild Hypothyroidism Being Overtreated, Avoid Pills, Says Panel
In a"strong recommendation," an international panel of experts advise that patients with subclinical hypothyroidism should not be routinely prescribed levothyroxine; evidence shows few benefits.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 16, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hundreds of thousands of people in the UK may be unnecessarily taking drugs
Figures from NHS Digital show that more than 32million prescriptions were issued in England in 2018 for levothyroxine. This is up from 20,426,378 in 2008. (Source: the Mail online | Health)
Source: the Mail online | Health - May 15, 2019 Category: Consumer Health News Source Type: news

TSH and Pregnancy: Finding Your Way Out of the Gray Zone TSH and Pregnancy: Finding Your Way Out of the Gray Zone
Which patients with subclinical hypothyroidism in pregnancy would benefit from levothyroxine treatment? Dr Korevaar shares three tips to help guide the decision-making process.Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 9, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news

ENDO: Levothyroxine Does Not Up Fertility in Women With TPO Ab
TUESDAY, March 26, 2019 -- For euthyroid women with thyroid peroxidase antibodies and a history of miscarriage or infertility, levothyroxine does not result in an increased rate of live births versus placebo, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2019 Category: Pharmaceuticals Source Type: news

Levothyroxine provides no pregnancy benefits to women with thyroid antibodies
According to data, presented at the Endocrine Society's annual meeting, euthyroid women treated with levothyroxine did not have improved chances of having a live birth, if they were also positive for thyroid antibodies.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 26, 2019 Category: Endocrinology Source Type: news

Levothyroxine Tx Doesn't Deliver in Women With TPO Antibodies
(MedPage Today) -- Preterm births and neonatal outcomes not significantly different than placebo (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - March 23, 2019 Category: OBGYN Source Type: news